May 21, 2021
Inspired by Dr. Raymond Hakim, the McGill Clinical Innovation Competition (CLIC) aims to inspire members of McGill’s Faculty of Medicine and Health Sciences community to conceive and develop promising ideas that will have a direct and positive impact on Canadian or global health care.
All finalists have been granted memberships to the Clinical Innovation Platform (CLIP), as a benefit along with their prizes.
First-Place Winners of the Marika Zelenka Roy Innovation Prize: Remote Optical
No high-quality remote examination method of the front of the eye exists. Our solution revolutionizes eye care with remote, asynchronous imaging and examination. These features improve access to eye care for people in rural/indigenous communities, senior homes, intensive care units and emergency rooms. Our solution saves money and time, and leverages the power of AI to assist ophthalmologists during exams and improve monitoring of changes in eye condition between consultations.
- Angela Wong, Co-founder, Remote Optical; Experimental Surgery, McGill University
- Jeremy Zwaig, Co-founder, Remote Optical; Experimental Surgery, McGill University
- Oliver Wu Martinez, Co-founder, Remote Optical; Experimental Surgery, McGill University
- Leonard Levin, MD, PhD, Co-founder & Academic Lead, Remote Optical; Ophthalmology & Visual Sciences and Neurology & Neurosurgery, McGill University
Second-place winners of the Marika Zelenka Roy Innovation Prize & Winners of the Bereskin & Parr Innovation Prize: NURA Medical
The process of preparing weight-based medication is not only time-consuming, but error-prone, which can ultimately lead to serious or even fatal consequences for pediatric patients. As such, NURA Medical has developed the IV Assistant, a semi-automated medical device to prevent medication errors. The IV Assistant will positively impact children receiving care across various healthcare settings and healthcare professionals lacking pediatric medicine expertise.
- Georgia Powell, COO, NURA Medical; Experimental Surgery, McGill University
- Sofia Addab, CCO, NURA Medical; Experimental Surgery, McGill University
- Jean-Gabriel Lacombe, CEO, NURA Medical; Experimental Surgery, McGill University
First-Place Winners of the MI4 Innovation Prize: LFAnt Medical
LFAnt Medical is a Canadian biotechnology startup dedicated to revolutionizing point-of-care diagnostics for at-home detection of sexually transmitted infections (STIs). Founded out of the Department of Bioengineering at McGill University in 2019, our student-led team combines proprietary biosensing technologies with the latest advances in microelectronics and machine learning to deliver accessible, inexpensive, and connected STI testing solutions.
- Adam Melnyk, Chief Product Officer, LFAnt Medical; Bioengineering, Faculty of Medicine and Health Sciences, McGill University
- Mark Kumhyr, Chief Executive Officer, LFAnt Medical
- Michael Phelan, Chief Operating Officer, LFAnt Medical; Bioengineering, Faculty of Medicine and Health Sciences, McGill University
- Patrick O’Neill, Chief Science Officer, LFAnt Medical; Bioengineering, Faculty of Medicine and Health Sciences, McGill University
Second-Place Winning Team of the MI4 Innovation Prize: Sensoreal
At Sensoreal, we have developed the first point-of-care blood test that was successfully commissioned at the International Space Station in 2019. In 2020 and in collaboration with Health Canada, we developed a prototype to differentiate bacterial/viral respiratory infections. Our technology uses disposable microfluidic chips using only a finger prick of blood and the data is analyzed using novel AI techniques. Our solution will help physicians to guide antibiotic therapy in less than 15 minutes.
- Pooya T. Saberi, Chief Executive Officer, Sensoreal; Mechanical Engineering, McGill University
- Kate Turner, Chief Technology Officer, Sensoreal; Department of Biomedical Engineering, Faculty of Medicine and Health Sciences, McGill University
- Hosseinali (Roozbeh) Safavieh, Chief Science Officer, Sensoreal; Department of Biomedical Engineering, Faculty of Medicine and Health Sciences, McGill University
Winner of the Hakim Family Innovation Prize: EzemaQ
EczemaQ is a pilot mobile health application available for download to clinician and/or patient smartphones for testing. This tool received an award from the Canadian Dermatology Association, and we have engaged a network of stakeholders, including industry, national patient advocacy groups, and the International Eczema Council. We are now validating usability of EczemaQ, using a co-development iterative process with REB-approval from the Center for Applied Ethics at the McGill University Health Centre
- Dr. Carolyn Jack, MDCM, PhD, Department of Medicine, McGill University Hospital Centre
- Charlie Bouchard, Co-Director, Eczéma Québec; Patient Partner, McGill University Hospital Network Center of Excellence for Atopic Dermatitis
- Valerie Jack, Co-Director, Eczéma Québec; Coordinator, McGill University Hospital Network Center of Excellence for Atopic Dermatitis
- Priya Patel, Project Manager, McGill University Hospital Network Center of Excellence for Atopic Dermatitis
- Gaurav Isola, Research Coordinator, McGill University Hospital Network Center of Excellence for Atopic Dermatitis
The CLIP Welcomes HOP TECH
The CLIP, powered by National Bank, and MEDTEQ+, are pleased to announce the addition of Sherbrooke-based HOP TECH as CLIP’s newest member.
The CLIP Welcomes Miraki Innovation
The Clinical Innovation Platform (CLIP), powered by National Bank, is delighted to announce its newest member, Cambridge, Massachusetts-based firm Miraki™ Innovation.
The CLIP Launch and Name Unveiling Event Slated for September 14, 2021
In conjunction with the Montreal General Hospital Foundation, the CLIP is hosting a launch event with major stakeholders, donors and the media. This event will also serve as a gift announcement and naming event from a major donor to fund start-ups incubated at CLIP.